Literature DB >> 17314226

Comparison of the Digene Hybrid Capture System Cytomegalovirus (CMV) DNA (version 2.0), Roche CMV UL54 analyte-specific reagent, and QIAGEN RealArt CMV LightCycler PCR reagent tests using AcroMetrix OptiQuant CMV DNA quantification panels and specimens from allogeneic-stem-cell transplant recipients.

Kimberly E Hanson1, L Barth Reller, Joanne Kurtzberg, Mitchell Horwitz, Gwynn Long, Barbara D Alexander.   

Abstract

The Digene Hybrid Capture system cytomegalovirus (CMV) DNA (version 2.0), Roche CMV UL54 analyte-specific reagent, and QIAGEN RealArt CMV LightCycler PCR reagent tests were compared using whole-virus standards and plasma specimens collected from allogeneic-stem-cell transplant recipients. PCR assays showed better speed, sensitivity, and specificity.

Mesh：

Substances：

Year:  2007        PMID： 17314226      PMCID： PMC1933098          DOI： 10.1128/JCM.02515-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  3 in total

1.  The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease.

Authors:  Raymund R Razonable; Robert A Brown; Jennie Wilson; Cynthia Groettum; Walter Kremers; Mark Espy; Thomas F Smith; Carlos V Paya
Journal:  Transplantation       Date:  2002-03-27       Impact factor: 4.939

2.  High variability between results of different in-house tests for cytomegalovirus (CMV) monitoring and a standardized quantitative plasma CMV PCR assay.

Authors:  Lutz Von Müller; Walter Hampl; Joachim Hinz; Helga Meisel; Angela Reip; Elisabeth Engelmann; Regine Heilbronn; Barbara Gärtner; Oliver Krämer; Hermann Einsele; Holger Hebart; Tatjana Ljubicic; Jürgen Löffler; Thomas Mertens
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

3.  Multicenter comparison of the digene hybrid capture CMV DNA assay (version 2.0), the pp65 antigenemia assay, and cell culture for detection of cytomegalovirus viremia.

Authors:  T Mazzulli; L W Drew; B Yen-Lieberman; D Jekic-McMullen; D J Kohn; C Isada; G Moussa; R Chua; S Walmsley
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948
  3 in total
  5 in total

1.  Quantification of DNA in plasma by an automated real-time PCR assay (cytomegalovirus PCR kit) for surveillance of active cytomegalovirus infection and guidance of preemptive therapy for allogeneic hematopoietic stem cell transplant recipients.

Authors:  Concepción Gimeno; Carlos Solano; José C Latorre; Juan C Hernández-Boluda; María A Clari; María J Remigia; Santiago Furió; Marisa Calabuig; Nuria Tormo; David Navarro
Journal:  J Clin Microbiol       Date:  2008-08-27       Impact factor: 5.948

2.  Comparative evaluation of three automated systems for DNA extraction in conjunction with three commercially available real-time PCR assays for quantitation of plasma Cytomegalovirus DNAemia in allogeneic stem cell transplant recipients.

Authors:  Dayana Bravo; María Ángeles Clari; Elisa Costa; Beatriz Muñoz-Cobo; Carlos Solano; María José Remigia; David Navarro
Journal:  J Clin Microbiol       Date:  2011-06-22       Impact factor: 5.948

3.  Monitoring of cytomegalovirus viral loads by two molecular assays in whole-blood and plasma samples from hematopoietic stem cell transplant recipients.

Authors:  N Esther Babady; Cindy Cheng; Evelyn Cumberbatch; Jeffrey Stiles; Genovefa Papanicolaou; Yi-Wei Tang
Journal:  J Clin Microbiol       Date:  2015-02-04       Impact factor: 5.948

4.  Comparative evaluation of the QIAsymphony RGQ system with the easyMAG/R-gene combination for the quantitation of cytomegalovirus DNA load in whole blood.

Authors:  Sylvie Pillet; Thomas Bourlet; Bruno Pozzetto
Journal:  Virol J       Date:  2012-10-09       Impact factor: 4.099

5.  Risk Factors for CMV Viremia and Treatment-Associated Adverse Events Among Pediatric Hematopoietic Stem Cell Transplant Recipients.

Authors:  Sarah M Heston; Rebecca R Young; John S Tanaka; Kirsten Jenkins; Richard Vinesett; Frances M Saccoccio; Paul L Martin; Nelson J Chao; Matthew S Kelly
Journal:  Open Forum Infect Dis       Date:  2021-12-16       Impact factor: 3.835
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.